(Live Webinar) The Changing Landscape of Ulcerative Colitis: Identification, New Methods of Treatment, and Implications in the COVID-19 Era
As an inflammatory condition, the management of ulcerative colitis (UC) in the current COVID-19 landscape is important as are several other elements of UC. With the growing number of UC patients, gastroenterology teams that include gastroenterologists, GI surgeons, nurses, nurse practitioners (NPs), physician assistants (PAs), and other valuable practitioners together will be essential to provide care for the increasing patient population.
It is vital that clinicians who manage a patient population on medications affecting the host inflammatory and immune responses be informed regarding adaptive ways to keep their patients safe. Centered on actual patient cases, this continuing education activity aims to provide UC care team members with the latest data regarding:
- Managing UC in the COVID-19 landscape;
- Insights into inflammation and the current pandemic;
- AASLD, ACG, AGA, and ASGE recent guideline updates;
- Potential mechanisms: ACE2 pathway; immunosuppressive therapy; others;
- Strategies for re-focusing care in UC;
- Overcoming barriers and adapting to changing treatment goals;
- Assessing novel treatments and future directions; and
- Best practices for team-based care approaches with improved patient communication.
Integral members of the multidisciplinary IBD patient care team including gastroenterologists, GI surgeons, NP/PAs, and nurses.
At the conclusion of this activity, participants will be able to (or better able to):
- Evaluate key considerations and the latest emerging data for managing ulcerative colitis and its associated comorbidities in the era of COVID-19.
- Describe several ways in which the management of UC has changed over the past two years, and ways to adapt to these changes in practice.
- Review current and evolving agents used for UC, regarding pharmacokinetics, efficacy, safety, and overall role in UC management.
- Assess ways in which to improve comprehensive UC care through communication with patients and involvement of other individuals on the care team.
Sharmeel K. Wasan, MD
Fellowship Director, Section of Gastroenterology
Boston Medical Center
Assistant Professor of Medicine
Boston University School of Medicine
Dr. Wasan has no relevant financial relationships to disclose.
Joseph D. Feuerstein, MD
Associate Clinical Chief, Gastroenterology
Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Associate Professor of Medicine
Harvard Medical School
Dr. Feuerstein has no relevant financial relationships to disclose.
Ryan Ungaro, MD
The Susan and Leonard Feinstein IBD Center
Mount Sinai Hospital
Assistant Professor of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai
New York City, New York
Dr. Ungaro is a consultant for Abbvie, Eli Lilly, Janssen, Pfizer and Takeda; he also receives research support fro Abbvie, Boehringer Ingelheim and Pfizer.
CME Project Manager: Michael Burk
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston University School of Medicine Continuing Nursing Education Provider Unit is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 1.25, all is eligible for pharmacology credit
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME Credits. Approval is valid from 8/31/2020 to 8/30/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200822.
According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN.
Contact Hours: 1.25 G.I. Specific Category 5 hours
- 1.25 AAPA Category I CME
- 1.25 ABCGNAccording to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN. Specific Category Approved: Hours Approved: 1.25
- 1.25 AMA PRA Category 1 Credit™Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 ANCCBoston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
- 1.25 Participation
Feugiat pretium nibh ipsum consequat nisl vel pretium lectus. Vehicula ipsum a arcu cursus vitae congue mauris rhoncus. Morbi leo urna molestie at elementum. Eget duis at tellus at. Molestie at elementum eu facilisis sed odio morbi quis. Egestas congue quisque egestas diam in arcu cursus euismod. Nunc scelerisque viverra mauris in aliquam sem fringilla ut. Sagittis nisl rhoncus mattis rhoncus urna neque. Viverra maecenas accumsan lacus vel. Purus in massa tempor nec feugiat nisl pretium fusce. Facilisi morbi tempus iaculis urna id. In vitae turpis massa sed elementum. Non tellus orci ac auctor augue mauris augue neque gravida. Diam sit amet nisl suscipit adipiscing bibendum est. Enim sit amet venenatis urna cursus. Velit ut tortor pretium viverra suspendisse potenti. Aliquam ultrices sagittis orci a scelerisque purus semper eget. Nisl purus in mollis nunc sed id. Turpis nunc eget lorem dolor sed viverra ipsum nunc.
Lobortis feugiat vivamus at augue. Id velit ut tortor pretium viverra suspendisse potenti nullam ac. Netus et malesuada fames ac turpis egestas integer eget. Augue ut lectus arcu bibendum at varius vel. Mattis molestie a iaculis at erat pellentesque adipiscing. Vitae semper quis lectus nulla at volutpat diam. Et malesuada fames ac turpis. Eu non diam phasellus vestibulum. Pellentesque elit ullamcorper dignissim cras tincidunt lobortis feugiat. Ligula ullamcorper malesuada proin libero nunc consequat interdum varius. Congue mauris rhoncus aenean vel. Imperdiet dui accumsan sit amet nulla facilisi morbi tempus iaculis. Ultrices vitae auctor eu augue. Egestas maecenas pharetra convallis posuere morbi leo. Faucibus et molestie ac feugiat sed lectus vestibulum. Viverra nam libero justo laoreet sit amet cursus sit. Justo donec enim diam vulputate ut pharetra sit amet.